Profil bibliographique

Arianna Draghi

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

265Publications signalées

724Citations signalées

1Affiliations récentes

Les institutions déclarées

Les domaines associés

Cancer Immunotherapy and BiomarkersCAR-T cell therapy researchGlioma Diagnosis and TreatmentImmunotherapy and Immune ResponsesRenal cell carcinoma treatment

Les publications récentes

Accès ouvert 2026 supplementary-materials OpenAlex

Supplementary Figures S1-S19 from Phenotypic and Functional Characteristics of CD8+ T Cells Predict Clinical Outcome Following TIL Therapy in a Randomized Phase III Trial in Advanced Melanoma

Joachim Stoltenborg Granhøj, Sigrid M.H. Mannering, Kasper Madsen, Helle W. Hendel et autres

Figure S1: Gating strategy Flow Panel 1. Supplementary Figure S2: Gating strategy Flow Panel 2 Supplementary Figure S3: Gating strategy Flow Panel 3 Supplementary Figure S4: Gating strategy Flow Panel 3 Supplementary Figure S5: Verification of patient-derived melanoma tumor cell lines using …

0 citations

Accès ouvert 2026 other OpenAlex

Data from Phenotypic and Functional Characteristics of CD8+ T Cells Predict Clinical Outcome Following TIL Therapy in a Randomized Phase III Trial in Advanced Melanoma

Joachim Stoltenborg Granhøj, Sigrid M.H. Mannering, Kasper Madsen, Helle W. Hendel et autres

Abstract Purpose: Adoptive cell therapy with tumor-infiltrating lymphocytes (TIL) is a highly personalized cancer immunotherapy. In the randomized phase III clinical trial [TIL-Netherlands Cancer Institute (NKI)/National Center for Cancer Immune Therapy (CCIT)], TIL therapy significantly improved progression-free survival (PFS) compared with ipilimumab …

0 citations

Accès ouvert 2026 supplementary-materials OpenAlex

Supplementary Tables S1-S10 from Phenotypic and Functional Characteristics of CD8+ T Cells Predict Clinical Outcome Following TIL Therapy in a Randomized Phase III Trial in Advanced Melanoma

Joachim Stoltenborg Granhøj, Sigrid M.H. Mannering, Kasper Madsen, Helle W. Hendel et autres

Supplementary Table S1: Overview of Antibodies Used for Flow Cytometry and Phenotyping. Supplementary Table S2: Overview of Antibodies Used for the Co-culture Assays and Intracellular Cytokine Staining Supplementary Table S3: Baseline Characteristics and Clinical Response Data Supplementary Table S4: Phenotypic Composition of …

0 citations

Accès ouvert 2026 other OpenAlex

Table S6 from Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways

Signe K. Skadborg, Simone Maarup, Arianna Draghi, Annie Borch et autres

Multivariate analysis of CA209-9UP patients (N=40).

0 citations

Accès ouvert 2026 other OpenAlex

Table S2 from Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways

Signe K. Skadborg, Simone Maarup, Arianna Draghi, Annie Borch et autres

Tissue overview

0 citations

Accès ouvert 2026 other OpenAlex

Figure S3 from Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways

Signe K. Skadborg, Simone Maarup, Arianna Draghi, Annie Borch et autres

Progression free survival and overall survival related for NIVO and CTRL patients.

0 citations

Accès ouvert 2026 other OpenAlex

Figure S14 from Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways

Signe K. Skadborg, Simone Maarup, Arianna Draghi, Annie Borch et autres

HLA expression on live cells in tumor digest

0 citations

Accès ouvert 2026 other OpenAlex

Figure S4 from Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways

Signe K. Skadborg, Simone Maarup, Arianna Draghi, Annie Borch et autres

Supplementary Figure 4

0 citations

Accès ouvert 2026 other OpenAlex

Figure S17 from Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways

Signe K. Skadborg, Simone Maarup, Arianna Draghi, Annie Borch et autres

Verification of detected NARTs.

0 citations

Accès ouvert 2026 other OpenAlex

Figure S9 from Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways

Signe K. Skadborg, Simone Maarup, Arianna Draghi, Annie Borch et autres

Supplementary Figure 9 Co-expression of Inhibitory molecules on intratumoral T cells.

0 citations

Accès ouvert 2026 other OpenAlex

Table S1 from Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways

Signe K. Skadborg, Simone Maarup, Arianna Draghi, Annie Borch et autres

Inclusion and exclusion criteria of the protocol

0 citations

Accès ouvert 2026 other OpenAlex

Table S7 from Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways

Signe K. Skadborg, Simone Maarup, Arianna Draghi, Annie Borch et autres

Multivariate analysis of CA209-9UP patients (N=40).

0 citations

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.